Pathophysiology of the Malignant Process

Introduction to Cellular Growth and Regulation

Normal cellular growth relies on a strict balance between cell division and cell death. The cell cycle is tightly controlled by checkpoints that ensure DNA is replicated accurately before a cell divides. When DNA sustained damage is detected, regulatory proteins either pause the cycle for repair or trigger programmed cell death, known as apoptosis.

Cancer arises when these regulatory controls fail. Mutations in the DNA accumulate, allowing cells to bypass checkpoints and divide uncontrollably. This loss of growth regulation transforms a normal, well-behaved cell into an autonomous entity focused solely on proliferation.

Characteristics of Benign Versus Malignant Neoplasms

Neoplasms are classified as either benign or malignant based on their growth behavior and potential to cause harm.

• Benign neoplasms: Localized growths that grow slowly, remain encapsulated, and do not spread to distant parts of the body. They typically have well-differentiated cells resembling the tissue of origin.
• Malignant neoplasms: Invasive growths characterized by rapid proliferation, poorly differentiated cells, and the ability to infiltrate surrounding tissues and spread through blood or lymphatic channels.

Genetic Basis of Cancer: Proto-oncogenes and Tumor Suppressor Genes

Cancer is fundamentally a genetic disease driven by mutations that alter gene expression. Two major categories of genes are consistently implicated:

• Proto-oncogenes: Normal genes that promote cell growth and division. When mutated, they become oncogenes, driving excessive, unregulated proliferation.
• Tumor suppressor genes: Normal genes that inhibit cell division and repair DNA damage. When inactivated by mutations, the cellular "brakes" are removed, allowing unchecked division.

Both gain-of-function mutations in proto-oncogenes and loss-of-function mutations in tumor suppressor genes must often occur together for a cancer to fully develop.

The Multistep Process of Carcinogenesis

Carcinogenesis occurs in three distinct phases: initiation, promotion, and progression.

1. Initiation: A permanent mutation occurs in the cellular DNA following exposure to a chemical, physical, or biological carcinogen. This altered cell remains dormant initially.
2. Promotion: Proliferative agents stimulate the initiated cell to divide repeatedly. During this phase, numerous cell divisions increase the likelihood of acquiring additional genetic errors.
3. Progression: The mutated cells undergo malignant changes, acquiring autonomous growth, invasiveness, and metastatic potential. The tumor becomes clinically detectable during this stage.

Tumor Angiogenesis and Blood Supply

As a tumor grows beyond a tiny size of one to two millimeters, simple diffusion of oxygen and nutrients becomes inadequate. To survive, the tumor must develop its own blood supply through a process called angiogenesis.

Tumor cells release chemical signals, most notably vascular endothelial growth factor (VEGF), which stimulate nearby host blood vessels to sprout new branches. These newly formed tumor vessels are typically tortuous, leaky, and structurally abnormal. This fragile vascular network not only feeds the growing neoplasm but also provides a ready pathway for tumor cells to enter the circulation.

Mechanisms of Tumor Invasion and Metastasis

Metastasis is the spread of cancer cells from the primary site to distant organs, accounting for the vast majority of cancer deaths. The process follows a cascade of sequential steps:

• Local invasion: Cancer cells detach from the primary mass and break through the surrounding extracellular matrix using enzymes called matrix metalloproteinases.
• Intravasation: The invasive cells penetrate the walls of local blood or lymphatic vessels.
• Circulation: Traveling cells survive immune surveillance within the bloodstream, often clumping with platelets for protection.
• Extravasation: Cells adhere to vessel walls at a distant site, exit the circulation, and invade the parenchyma of the new organ.
• Colonization: The migrated cells multiply in their new microenvironment to form secondary tumors.

Host Immune Response and Tumor Evasion

The immune system has mechanisms to recognize and destroy abnormal cells through cytotoxic T lymphocytes and natural killer cells. Tumor cells express altered surface antigens that should trigger this immune defense.

However, successful cancers employ various strategies to evade detection and destruction. Some tumors downregulate their surface antigens, making them invisible to patrolling lymphocytes. Others secrete immunosuppressive cytokines or express surface proteins that actively deactivate attacking immune cells. This immune escape allows the malignancy to persist and proliferate unchecked within the host.